PROGNOSYS BIOSCIENCES INC has a total of 93 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and chemical engineering are ABBOTT MOLECULAR INC, PANOMICS INC and ACOLYTE BIOMEDICA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 49 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 10 | |
#4 | China | 9 | |
#5 | Australia | 4 | |
#6 | Canada | 4 | |
#7 | Hong Kong | 4 | |
#8 | Hungary | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Chemical engineering | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Chee Mark S | 81 |
#2 | Routenberg David A | 15 |
#3 | Kozlov Igor A | 15 |
#4 | Altin John Andrew | 11 |
#5 | Routenberg David | 10 |
#6 | Chee Mark | 8 |
#7 | Capek Petr | 7 |
#8 | Kosakovsky Pond Stephanie J | 2 |
#9 | Wentworth Anita D | 2 |
#10 | Chee Mark S S | 1 |
Publication | Filing date | Title |
---|---|---|
US2019300945A1 | Spatially Encoded Biological Assays | |
US2019271031A1 | Spatially encoded biological assays | |
US2016291007A1 | Polynucleotide conjugates and methods for analyte detection | |
AU2014203638A1 | Spatially encoded biological assays | |
CN111500680A | Method and system for detecting spatial distribution of biological targets in a sample | |
CN105358984A | Methods for detecting peptide/MHC/TCR binding | |
EP2771450A1 | Methods for manufacturing molecular arrays | |
WO2012139110A2 | Peptide constructs and assay systems | |
US2011245101A1 | Co-localization affinity assays | |
EP2556171A1 | Spatially encoded biological assays | |
CN102648294A | Peptide display arrays | |
AU2010278710A1 | Assay tools and methods of use |